The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Causalgia

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Causalgia

 

Psychiatry related information on Causalgia

 

High impact information on Causalgia

 

Chemical compound and disease context of Causalgia

 

Biological context of Causalgia

 

Anatomical context of Causalgia

 

Gene context of Causalgia

  • While further studies are required, these findings suggest that accumulation of SNS/PN3 and/or loss of GDNF may contribute to pain in causalgia, and that selective blockers of SNS/PN3 and/or rhGDNF may provide effective novel treatments [21].
  • A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II [22].
  • Part I (in this issue) presents theoretical aspects and Part II (in Vol. 9 No. 3) will present management aspects of deafferentation pain [23].
  • Evaluation of beta-endorphin/beta-lipotropin immunoreactivity content in the CSF of patients affected by deafferentation pain syndromes [24].
 

Analytical, diagnostic and therapeutic context of Causalgia

References

  1. Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Levine, J.D., Taiwo, Y.O., Collins, S.D., Tam, J.K. Nature (1986) [Pubmed]
  2. Reflex sympathetic dystrophy (causalgia) treatment with guanethidine. Tabira, T., Shibasaki, H., Kuroiwa, Y. Arch. Neurol. (1983) [Pubmed]
  3. Physical findings in patients with chronic intractable benign pain of the neck and/or back. Rosomoff, H.L., Fishbain, D.A., Goldberg, M., Santana, R., Rosomoff, R.S. Pain (1989) [Pubmed]
  4. A man for all seasons: W.W. Keen. Rovit, R.L., Couldwell, W.T. Neurosurgery (2002) [Pubmed]
  5. Lamotrigine for pain with hyperalgesia. Harbison, J., Dennehy, F., Keating, D. Irish medical journal. (1997) [Pubmed]
  6. The effect of tryptophan supplementation on autotomy induced by nerve lesions in rats. Abbott, F.V., Young, S.N. Pharmacol. Biochem. Behav. (1991) [Pubmed]
  7. And still capsaicin causes causalgia. Shuster, S. Lancet (1995) [Pubmed]
  8. Capsaicin and the cause of causalgia. Shuster, S. Lancet (1995) [Pubmed]
  9. Epidural and oral clonidine in domiciliary control of deafferentation pain. Petros, A.J., Wright, R.M. Lancet (1987) [Pubmed]
  10. The causalgia-dystonia syndrome. Bhatia, K.P., Bhatt, M.H., Marsden, C.D. Brain (1993) [Pubmed]
  11. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Guo, T.Z., Offley, S.C., Boyd, E.A., Jacobs, C.R., Kingery, W.S. Pain (2004) [Pubmed]
  12. An unusual case of causalgia. Relevance to recent hypothesis on mechanism of causalgia. Hopkins, C.S., Charters, P. Pain (1989) [Pubmed]
  13. Trazodone for deafferentation pain. Comparison with amitriptyline. Ventafridda, V., Caraceni, A., Saita, L., Bonezzi, C., De Conno, F., Guarise, G., Ramella, G., Silvani, V., Tamburini, M., Toscani, F. Psychopharmacology (Berl.) (1988) [Pubmed]
  14. Continuous intrathecal baclofen infusion in the management of central deafferentation pain. Becker, R., Uhle, E.I., Alberti, O., Bertalanffy, H. Journal of pain and symptom management. (2000) [Pubmed]
  15. Phenoxybenzamine in the treatment of causalgia. Report of 40 cases. Ghostine, S.Y., Comair, Y.G., Turner, D.M., Kassell, N.F., Azar, C.G. J. Neurosurg. (1984) [Pubmed]
  16. Relief of causalgia with prostaglandin E1 ointment. Mashimo, T., Tomi, K., Pak, M., Demizu, A., Yoshiya, I. Anesth. Analg. (1991) [Pubmed]
  17. Deafferentation pain exacerbated by subarachnoid lidocaine and relieved by subarachnoid morphine. Case report. Iacono, R.P., Boswell, M.V., Neumann, M. Regional anesthesia. (1994) [Pubmed]
  18. Epidural clonidine in lower limb deafferentation pain. Coventry, D.M., Todd, G. Anesth. Analg. (1989) [Pubmed]
  19. Deafferentation pain after spinal cord injury. Part II. Management. Segatore, M. SCI nursing : a publication of the American Association of Spinal Cord Injury Nurses. (1992) [Pubmed]
  20. Location of a DBS-electrode in lateral thalamus for deafferentation pain. An autopsy case report. Kuroda, R., Nakatani, J., Yamada, Y., Yorimae, A., Kitano, M. Acta neurochirurgica. Supplementum. (1991) [Pubmed]
  21. Increased sodium channel SNS/PN3 immunoreactivity in a causalgic finger. Shembalkar, P.K., Till, S., Boettger, M.K., Terenghi, G., Tate, S., Bountra, C., Anand, P. European journal of pain (London, England) (2001) [Pubmed]
  22. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Kingery, W.S., Davies, M.F., Clark, J.D. Pain (2003) [Pubmed]
  23. Deafferentation pain after spinal cord injury. Part I. theoretical aspects. Segatore, M. SCI nursing : a publication of the American Association of Spinal Cord Injury Nurses. (1992) [Pubmed]
  24. Evaluation of beta-endorphin/beta-lipotropin immunoreactivity content in the CSF of patients affected by deafferentation pain syndromes. Salar, G., Alessio, L., Govoni, S., Battaini, F., Iob, I., Goss, I., Trabucchi, M. Pharmacol. Res. (1991) [Pubmed]
  25. Intravenous regional guanethidine in the treatment of reflex sympathetic dystrophy/causalgia: a randomized, double-blind study. Guanethidine Study Group. Ramamurthy, S., Hoffman, J. Anesth. Analg. (1995) [Pubmed]
  26. Amenorrhea in a patient after treatment with gabapentin for complex regional pain syndrome type II. Berger, J.J. The Clinical journal of pain. (2004) [Pubmed]
 
WikiGenes - Universities